Cosoreanu Andrada, Rusu Emilia, Rusu Florin, Stanciu Silviu, Enache Georgiana, Radulian Gabriela
Diabetes and Endocrinology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, ROU.
Diabetes, "Carol Davila" University of Medicine and Pharmacy, Bucharest, ROU.
Cureus. 2024 Jun 10;16(6):e62118. doi: 10.7759/cureus.62118. eCollection 2024 Jun.
Background Chronic kidney disease (CKD) poses a significant health challenge among patients, contributing to substantial morbidity and mortality outcomes. However, there remains a paucity of data within the medical literature on the Roma population, one of the most significant minority groups globally, with studies indicating that these individuals are disproportionately affected by CKD compared to the general population, with higher prevalence rates. Materials and methods We conducted an observational, cross-sectional study from October 2022 to March 2024, evaluating 735 adult patients with type 2 diabetes mellitus, of which 402 were Roma, aged 18 to 89 years, following the hospital's standard protocols for diabetes management, at the "Nicolae Malaxa" Clinical Hospital in Bucharest, Romania, a tertiary care center for diabetes. Results The prevalence of CKD was higher among the Roma patients, reaching 56.50% (n=203), in comparison with the Caucasian group (43.50%, n=156), however, with a lower mean age (55.53±10.56 years versus 63.32±10.04 years). Roma patients with CKD had a higher prevalence of cardiovascular disease compared to Caucasians, including myocardial infarction, stroke, stable angina, and heart failure. Cardiovascular risk factors, such as hypertension, obesity, and dyslipidemia, in patients with CKD, were also more prevalent among the Roma population. Taking into consideration the natural progression of CKD, the anthropometric measurements and laboratory parameters stratified by ethnicity revealed that Roma patients in the very high risk of CKD progression category had a lower mean age, and a lower median duration of diabetes (56.37±10.79 versus 59.92±7.48 years, and 4.00±2.00 versus 10.00±10.30 years, respectively), as well as a more elevated mean waist circumference (WC), body mass index (BMI), total cholesterol (TC), and low-density lipoprotein-cholesterol (LDL-c) compared to Caucasians. Moreover, patients in the very high risk of CKD progression category among both groups showed the highest level of insulin resistance, measured by the triglyceride-glucose (TyG) index (mean value of 10.13±0.60 among the Roma patients, and 10.09±0.82 among Caucasians). Among the study group, weight, WC, BMI, and A Body Shape Index (ABSI) were associated with a very high risk of progression of CKD. In Caucasian patients, it was demonstrated that weight, WC, BMI, ABSI, and triglycerides (TG) have contributed to the very high risk of progression of CKD, while among the Roma patients, no association was found. Conclusion In conclusion, our findings suggested a high prevalence of CKD among both groups. There is still a need for further investigation of additional risk factors, such as genetics, limited access to health education, and appropriate treatments that could synergistically accelerate the progression of CKD among Roma patients.
慢性肾脏病(CKD)给患者带来了重大的健康挑战,导致了大量的发病和死亡后果。然而,在医学文献中,关于罗姆人群体的数据仍然匮乏,罗姆人是全球最重要的少数群体之一,研究表明,与普通人群相比,这些个体受CKD的影响更大,患病率更高。
我们于2022年10月至2024年3月进行了一项观察性横断面研究,评估了735例2型糖尿病成年患者,其中402例为罗姆人,年龄在18至89岁之间,按照罗马尼亚布加勒斯特“尼古拉·马拉克萨”临床医院(一家糖尿病三级护理中心)的糖尿病管理标准方案进行研究。
与白种人群体(43.50%,n = 156)相比,罗姆患者中CKD的患病率更高,达到56.50%(n = 203),不过,罗姆患者的平均年龄较低(55.53±10.56岁对63.32±10.04岁)。与白种人相比,患有CKD的罗姆患者心血管疾病的患病率更高,包括心肌梗死、中风、稳定型心绞痛和心力衰竭。CKD患者中的心血管危险因素,如高血压、肥胖和血脂异常,在罗姆人群体中也更为普遍。考虑到CKD的自然进展,按种族分层的人体测量学指标和实验室参数显示,处于CKD进展极高风险类别的罗姆患者平均年龄较低,糖尿病病程中位数也较低(分别为56.37±10.79岁对59.92±7.48岁,以及4.00±2.00年对10.00±10.30年),而且与白种人相比,平均腰围(WC)、体重指数(BMI)、总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-c)更高。此外,两组中处于CKD进展极高风险类别的患者胰岛素抵抗水平最高,通过甘油三酯 - 葡萄糖(TyG)指数测量(罗姆患者的平均值为10.13±0.60,白种人为10.09±0.82)。在研究组中,体重、WC、BMI和体脂形状指数(ABSI)与CKD进展的极高风险相关。在白种患者中,已证明体重、WC、BMI、ABSI和甘油三酯(TG)促成了CKD进展的极高风险,而在罗姆患者中未发现相关性。
总之,我们的研究结果表明两组中CKD的患病率都很高。仍需要进一步调查其他风险因素,如遗传因素、获得健康教育的机会有限以及可能协同加速罗姆患者CKD进展的适当治疗方法。